Harvard Bioscience Stock Technical Analysis
| HBIO Stock | USD 0.57 0.02 3.39% |
As of the 4th of March, Harvard Bioscience retains the Standard Deviation of 4.41, market risk adjusted performance of (0.20), and Risk Adjusted Performance of (0.04). Harvard Bioscience technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Harvard Bioscience Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Harvard, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HarvardHarvard Bioscience's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Harvard Bioscience Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 2.0 | Buy | 2 | Odds |
Most Harvard analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Harvard stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Harvard Bioscience, talking to its executives and customers, or listening to Harvard conference calls.
Will Life Sciences Tools & Services sector continue expanding? Could Harvard diversify its offerings? Factors like these will boost the valuation of Harvard Bioscience. Market participants price Harvard higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Harvard Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.80) | Earnings Share (1.16) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets |
Harvard Bioscience's market price often diverges from its book value, the accounting figure shown on Harvard's balance sheet. Smart investors calculate Harvard Bioscience's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Harvard Bioscience's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Harvard Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Harvard Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Harvard Bioscience.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in Harvard Bioscience on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Harvard Bioscience or generate 0.0% return on investment in Harvard Bioscience over 90 days. Harvard Bioscience is related to or competes with Nexgel, Retractable Technologies, Femasys, Nexalin Technology, TAO Synergies, NuCana PLC, and Cosmos Health. Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental... More
Harvard Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Harvard Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Harvard Bioscience upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 23.21 | |||
| Value At Risk | (6.49) | |||
| Potential Upside | 6.38 |
Harvard Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Harvard Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Harvard Bioscience's standard deviation. In reality, there are many statistical measures that can use Harvard Bioscience historical prices to predict the future Harvard Bioscience's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.21) |
Harvard Bioscience March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.20) | |||
| Mean Deviation | 3.33 | |||
| Coefficient Of Variation | (1,470) | |||
| Standard Deviation | 4.41 | |||
| Variance | 19.47 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.21) | |||
| Maximum Drawdown | 23.21 | |||
| Value At Risk | (6.49) | |||
| Potential Upside | 6.38 | |||
| Skewness | 0.7316 | |||
| Kurtosis | 1.33 |
Harvard Bioscience Backtested Returns
Harvard Bioscience holds Efficiency (Sharpe) Ratio of -0.0637, which attests that the entity had a -0.0637 % return per unit of risk over the last 3 months. Harvard Bioscience exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Harvard Bioscience's Risk Adjusted Performance of (0.04), market risk adjusted performance of (0.20), and Standard Deviation of 4.41 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.45, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Harvard Bioscience will likely underperform. At this point, Harvard Bioscience has a negative expected return of -0.29%. Please make sure to check out Harvard Bioscience's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Harvard Bioscience performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.45 |
Modest reverse predictability
Harvard Bioscience has modest reverse predictability. Overlapping area represents the amount of predictability between Harvard Bioscience time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Harvard Bioscience price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Harvard Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Harvard Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Harvard Bioscience Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Harvard Bioscience across different markets.
About Harvard Bioscience Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Harvard Bioscience on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Harvard Bioscience based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Harvard Bioscience price pattern first instead of the macroeconomic environment surrounding Harvard Bioscience. By analyzing Harvard Bioscience's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Harvard Bioscience's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Harvard Bioscience specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.002551 | 0.002218 | Price To Sales Ratio | 1.12 | 1.69 |
Harvard Bioscience March 4, 2026 Technical Indicators
Most technical analysis of Harvard help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Harvard from various momentum indicators to cycle indicators. When you analyze Harvard charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.20) | |||
| Mean Deviation | 3.33 | |||
| Coefficient Of Variation | (1,470) | |||
| Standard Deviation | 4.41 | |||
| Variance | 19.47 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.21) | |||
| Maximum Drawdown | 23.21 | |||
| Value At Risk | (6.49) | |||
| Potential Upside | 6.38 | |||
| Skewness | 0.7316 | |||
| Kurtosis | 1.33 |
Harvard Bioscience March 4, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Harvard stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 13,638 | ||
| Daily Balance Of Power | (0.50) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 0.58 | ||
| Day Typical Price | 0.58 | ||
| Price Action Indicator | (0.02) |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harvard Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Will Life Sciences Tools & Services sector continue expanding? Could Harvard diversify its offerings? Factors like these will boost the valuation of Harvard Bioscience. Market participants price Harvard higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Harvard Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.80) | Earnings Share (1.16) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets |
Harvard Bioscience's market price often diverges from its book value, the accounting figure shown on Harvard's balance sheet. Smart investors calculate Harvard Bioscience's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Harvard Bioscience's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.